Reverse cardio-oncology highlights the heightened risk of cancer in patients with cardiovascular disease, driven by shared mechanisms like chronic inflammation and clonal hematopoiesis.
The emerging concept of reverse cardio-oncology highlights the heightened risk of cancer in patients with cardiovascular disease, driven by shared mechanisms like chronic inflammation and clonal haematopoiesis.
Having established the significance of cardiovascular side-effects of anti-neoplastic drugs, present day cardio-oncology has forayed into newer territories buoyed by research into the multiple connections that exist between cardiovascular disease and cancer. An emerging concept of reverse cardio-oncology focuses on the heightened risk of cancer in patients with cardiovascular disease. Common mechanistics of cancer and heart failure (HF) like chronic inflammation and clonal haematopoesis as well as common predisposing factors like obesity and diabetes underline the relation between both cardiovascular disease and various cancers.This review discusses the potential magnitude of the problem, the underlying pathophysiological mechanisms and classification of this novel subject.
Satpathy et al. (Wed,) conducted a review in Cardiovascular disease and cancer. Cardiovascular disease was evaluated. Reverse cardio-oncology highlights the heightened risk of cancer in patients with cardiovascular disease, driven by shared mechanisms like chronic inflammation and clonal hematopoiesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: